Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy

Objective To compare short-term therapeutic effect of different regimens combining recombinant human thrombopoietin(rh TPO)with immunosuppressive therapy(IST)applied in severe aplastic anemia(SAA).Methods The clinical data of newly diagnosed adult SAA patients treated with first-line IST,including 18